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Abstract. Catechol 1,2-dioxygenase (CTD) and protocatechuate 3,4-dioxygenase (PCD) are bacterial 
non-heme iron enzymes, which catalyse the oxidative cleavage of catechols to cis, cis-muconic acids with 
the incorporation of molecular oxygen via a mechanism involving a high-spin ferric centre. The iron(III) 
complexes of tripodal phenolate ligands containing N3O and N2O2 donor sets represent the metal binding re-
gion of the iron proteins. In our laboratory iron(III) complexes of mono- and bisphenolate ligands have 
been studied successfully as structural and functional models for the intradiol-cleaving catechol dioxy-
genase enzymes. The single crystal X-ray crystal structures of four of the complexes have been deter-
mined. One of the bis-phenolato complexes contains a FeN2O2Cl chromophore with a novel trigonal 
bipyramidal coordination geometry. The Fe–O–C bond angle of 136⋅1° observed for one of the iron(III) 
complex of a monophenolate ligand is very similar to that in the enzymes. The importance of the nearby 
sterically demanding coordinated –NMe2 group has been established and implies similar stereochemical con-
straints from the other ligated amino acid moieties in the 3,4-PCD enzymes, the enzyme activity of which 
is traced to the difference in the equatorial and axial Fe–O(tyrosinate) bonds (Fe–O–C, 133, 148°). The 
nature of heterocyclic rings of the ligands and the methyl substituents on them regulate the electronic 
spectral features, FeIII/FeII redox potentials and catechol cleavage activity of the complexes. Upon inter-
acting with catecholate anions, two catecholate to iron(III) charge transfer bands appear and the low energy 
band is similar to that of catechol dioxygenase-substrate complex. Four of the complexes catalyze the 
oxidative cleavage of H2DBC by molecular oxygen to yield intradiol cleavage products. Remarkably, the 
more basic N-methylimidazole ring in one of the complexes facilitates the rate-determining product-
releasing phase of the catalytic reaction. The present study provides support to the novel substrate activa-
tion mechanism proposed for the intradiol-cleavage enzymes. 
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1. Introduction 
Mononuclear non-heme iron centres are frequently 
present in a variety of protein systems which perform 
important biological functions involving dioxygen.1–4 
The oxidative cleavage of catechol and other dihy-
droxy aromatics is a key step in the biodegradation 
by soil bacteria of naturally occurring aromatic mole-
cules and many aromatic environmental pollutants.6 
The mononuclear non-heme iron proteins that cata-
lyse the oxidative cleavage5 of catechol or its deri-
vatives with the incorporation of molecular oxygen 
are exemplified by catechol dioxygenases. If two of 
the hydroxyl substituents in the catechol substrate 
are in ortho positions then ring cleavage can occur 
either between the two groups (intradiol) or between 
one hydroxyl group and an adjacent carbon atom 
(extradiol).7 The X-ray crystal structure of the intra-
diol cleaving protocatechuate 3,4-dioxygenase 
(PCD) from Pseudomonas putida reveals a trigonal 
bipyramidal iron(III) site with four endogenous pro-
tein ligands (Tyr408, Tyr447, His460 and His462) 
and a solvent-derived ligand.8 A very similar active 
site has been found9 recently for another member of 
the intradiol dioxygenase family, namely, catechol 
1,2-dioxygenase (CTD). The spectroscopic proper-
ties of the Fe(III) centre are alter by substrate bind-
ing to active site. 
 As the interaction of iron(III) with phenolate moie-
ties of tyrosine residues plays an important role in 
the enzyme function and in stabilizing the active site 
geometries of CTD and PCD enzymes, iron(III) com-
plexes of phenolate ligands have attracted much in-
terest as models to mimic the enzyme active sites 
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and function. From the point of view of models for 
dioxygenases, fundamental work by Funabiki et al 
on the catalytic intra- and extradiol oxygenations of 
3,5-di-tert-butylcatechol (H2DBC) by a py/bipy/FeCl3 
complex appeared.10–12 In early studies Que and co-
workers13–15 synthesised a series of nitrogen, carboxy-
late and phenolate containing iron(III) complexes, 
the catalytic properties of which have been explored. 
Indeed they found a clear relationship between the 
reactivity of the adducts and Lewis acidity of the 
iron(III) centres as modulated by the tripodal ligand, 
which plays an important role in dictating the cate-
cholate-to-iron(III) charge transfer absorptions oc-
curring in the visible region. The tripodal ligand 
complexes reported by Nishida16 and Que13,15 to effect 
oxidative cleavage contain a coordinated phenolate 
group, in addition to pyridyl moieties. 
 Model compounds synthesised17–19 previously by 
us are derived from both mono- and bis(phenolate) 
tripodal ligands with pyridine/benzimidazole pen-
dants and were used to cleave the substrate analogue 
H2DBC. These ligands provide a reasonable ana-
logue to histidine and tyrosinate coordination in 
CTD enzyme via the bzim and phenolate moieties. 
The study of iron(III) complexes of certain simple 
tridentate ligands with both phenolate and imidazole 
functionalities also provided the information perti-
nent to understanding of structure vs spectra correla-
tions and the function and reactivity of the active 
site. A linear correlation between the FeIII/FeII redox 
potential and the CT band energy of complexes was 
obtained. The catalytic activity of the complexes has 
been correlated with the FeIII/FeII as well DBSQ/ 
DBC [DBSQ = 3,5-di-tert-butyl-1,2-benzoquinone] 
redox couples. Also the dioxygenase activity was illu-
strated on the basis of the Lewis acidity of the com-
plex-DBC2– adducts, derived from the magnitude of 
the CAT2–/DBC2– → Fe(III) CT band energy and the 
E1/2 of the DBSQ/DBC2– couple and steric hindrance 
to substrate binding and by assuming that the product 
release is the rate-determining phase of the reaction. 
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Scheme 1. Cleavage modes of catechol. 
 In the present review we summarise our very re-
cent work18,19 on synthetic analogues for intradiol-
cleaving catechol dioxygenases. We have isolated 
mononuclear iron(III) complexes of sterically hin-
dered tetradentate mono- and bisphenolate ligands, 
which are expected to closely mimic the enzyme ac-
tive site structure and function. The steric and elec-
tronic influence of the ligand nitrogen donor set on 
the spectral and redox behaviour and the dioxy-
genase activity of the complexes has been probed. 
The X-ray crystal structures of some of the com-
plexes have been determined to demonstrate the 
availability of two cis coordination sites for adduct 
formation by substrate molecules. We have used 
H2DBC as the model substrate and the advantages 
are the relatively high stability of the main cleavage 
product and the fast reaction of the catecholate com-
plexes with dioxygen. 
2. Synthesis of mono- and bis-phenolate ligands 
and isolation of their iron(III) complexes 
The monophenolate ligands 2-bis(pyrid-2-ylmethyl) 
aminomethyl-4-nitrophenol [H(L1)], N,N-dimethyl-
N′-(pyrid-2-yl-methyl)-N′-(2-hydroxy-4-nitrobenzyl) 
ethylene-diamine [H(L2)], N,N-dimethyl-N′-(6-
methylpyrid-2-ylmethyl)-N′-(2-hydroxy-4-nitrobenzyl)-
ethylenediamine H(L3)] and N,N-dimethyl-N′-(1-
methylimidazole-2-ylmethyl)-N′-(2-hydroxy-4-nitro- 
benzyl)ethylenediamine H(L4) (scheme 2) were syn-
thesized according to known procedures,18,20 which 
involve simple substitution reactions. They may be 
regarded as derivatives of the exclusively pyridine 
containing ligand TPA. The pendant pyridine/imidazole 
functionality has been incorporated into the ligand 
to provide a systematic variation in the Lewis acidity 
of the iron(III) centre. The bulky N,N-dimethyl group, 
the pyridine ring nitrogen sterically hindered by 6-
methyl group and the more basic N-methylimidazole 
moiety [pKa (BH+): imidazole, 6⋅0; pyridine, 5⋅2] in 
the ligands are expected to influence the iron(III) 
coordination structures as well as the electronic 
properties of the complexes and offer steric hin-
drance to the substrates so as to closely approximate 
the active site in enzyme–substrate complexes. The 
tetradentate ligands provide a reasonable analogue 
to histidine and tyrosinate coordination in CTD and 
PCD enzymes via the heterocyclic nitrogen donors 
and phenolate moieties respectively. The iron(III) 
complexes of the monophenolate ligands are formu-
lated as [Fe(L1)Cl2].CH3CN (1), [Fe(L2)Cl2] (2), 
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[Fe(L3)Cl2] (3) and [Fe(L4)Cl2] (4), which is sup-
ported by the X-ray crystal structures of 1 and 2 (cf. 
below). 
 The bisphenolate ligands N,N-dimethyl-N′,N′-
bis(2-hydroxy-3,5-dimethyl-benzyl)ethylenediamine 
[H2(L5)], N,N-dimethyl-N′,N′-bis(2-hydroxy-4-nitro-
benzyl)ethylenediamine [H2(L6)], N,N′-dimethyl-
N,N′-bis(2-hydroxy-3,5-dimethylbenzyl)-ethylene-
diamine [H2(L7)] and N,N′-dimethyl-N,N′-bis(2-
hydroxy-4-nitrobenzyl)ethylenediamine [H2(L8)] 
(scheme 2) were synthesised according to known 
procedures, which involve Mannich condensation 
and simple substitution reactions.19,21 The complexes 
of [H2(L5)] and [H2(L7)] are formulated as [Fe(L5)Cl] 
5 and [Fe(L7)Cl] 7 while those of [H2(L6)] and 
[H2(L8)] as [Fe(L6)(H2O)Cl] 6 and [Fe(L8)(H2O)Cl] 
8, which is supported by the X-ray crystal structures 
of 5 and 6 (cf. below).  
3. Description of the X-ray crystal structures  
of [Fe(L1)Cl2].CH3CN, 1, [Fe(L2)Cl2], 2, 
[Fe(L5)Cl], 5 and [Fe(L6)(H2O)Cl], 6  
Both the complex molecules [Fe(L1)Cl2]⋅CH3CN, 1 
and [Fe(L2)Cl2], 2 have a FeN3OCl2 coordination sphere  
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Scheme 2. Structures of the mono- and bisphenolate 
ligands. 
with a distorted octahedral geometry, constituted by 
three nitrogen atoms and one phenolate oxygen atom 
from the tripodal ligand and two chloride ions. In 2 
the Fe–N3 bond is significantly longer than the Fe–
N2 bond due to the inability of the sterically hinder-
ing –NMe2 group to properly orient itself towards 
iron(III). The observed Fe–O1 distance (1⋅929 Å) is 
shorter17–19 than the average octahedral FeIII–O dis-
tance of ~ 1⋅98 Å suggesting strong iron–oxygen 
overlap.22 The phenolate oxygen in the six-membered 
chelate ring has a Fe–O1–C13 bond angle of 136⋅1°, 
which is higher than the ideal value of 120° for sp2 
hybridized phenolate oxygen atom indicating that 
the latter (in-plane ppi orbital) interacts less strongly 
with a half-filled dpi* orbital on iron(III). Also, the 
angle is higher than the average Fe–O–C bond angle 
of ~ 128⋅5° observed in other octahedral iron(III)-
phenolate complexes.17–19,22,23 
 A comparison of the structural parameters of 2
 
with those of 1. CH3CN reveals remarkable differ- 
 
 
 
 
 
 
 
Figure 1. Structures of [Fe(L1)Cl2]⋅CH3CN 1 and 
[Fe(L2)Cl2] 2 showing the atom numbering scheme and 
the thermal motion ellipsoids (50% probability level) for 
the non-hydrogen atoms. 
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ences in their structures. The replacement of one of 
the pyridine pendants in 1. CH3CN by the sterically 
demanding –NMe2 group to obtain 2 results in short-
ening of Fe–N but elongation of Fe–Cl bonds. The 
replacement of pyridine moiety in 1. CH3CN by the 
sterically demanding –NMe2 group enhances the Fe-
O–C bond angle from 128⋅5° to 136⋅1° but decreases 
the Fe–O–C–C dihedral angle from 59⋅0° to 15⋅2°. 
This enhances the pi-back bonding, which involves the 
dpi orbitals of iron and the relatively low lying pi*  
orbital (vs phenolate ion) of the weakly σ-bonding 
p-nitrophenolate, leading to a stronger Fe–O bond. 
This illustrates the importance of extended pi-
delocalisation involving p-nitrophenolate and iron(III) 
d-orbitals. 
 The coordination environment around the iron 
atom in [Fe(L5)Cl] 5 is described as distorted trigo-
nal bipyramidal. The metal is bonded to two phe-
nolate oxygens (O1, O2) and the amine nitrogen 
(N2) of the tripodal ligand, which define the trigonal 
plane of the bipyramid, and the other amine nitrogen  
 
 
 
Figure 2. Structures of [Fe(L5)Cl] 5 and [Fe(L6) 
(H2O)Cl] 6 showing the atom numbering scheme and the 
thermal motion ellipsoids (50% probability level) for the 
non-hydrogen atoms. 
(N1) and chloride ion occupy the apical sites. The 
observed Fe–O bond distances (Fe–O1, 1⋅867; Fe-
O2, 1⋅855 Å) in 5 are shorter17–19 than the average 
octahedral Fe–O bond distance of 1⋅92 Å implying 
relatively strong iron–oxygen overlap,22 which is 
consistent with the lower coordination number. The 
Fe–O–C bond angles (Fe–O1–C1, 122⋅05; Fe–O2–
C18, 122⋅15°) are much less than those in octahedral 
iron(III) complexes of phenolate ligands (~ 128⋅5°) 
but are closer to the ideal value of 120° for sp2 hy-
bridized phenolate oxygen atom suggesting that the 
latter interacts22 more strongly with a half-filled dpi* 
orbital in iron(III) in the present complexes the co-
ordination geometry around iron(III) is trigonal 
bipyramidal with the trigonality index τ of 0⋅79 
[τ = (β – α)/60, where β, N1–Fe–Cl1 = 170⋅14° and 
α, O1–Fe-–N2 = 123⋅05°; for perfect square pyrami-
dal and trigonal bipyramidal geometries the τ values 
are zero and unity respectively]. Interestingly, this 
coordination environment is closely related to the 
trigonal bipyramidal metal core (τ, 0⋅44) in the sub-
strate-free 3,4-PCD enzyme; however, both the phe-
nolates are equatorial in 5, while they are mixed 
axial–equatorial in the enzyme active site.  
 The complex [Fe(L6)(H2O)Cl] 6 exhibits distorted 
octahedral coordination geometry constituted by two 
trans-coordinated phenolate oxygen atoms (O1, O4) 
and the cis-coordinated amine nitrogen atoms (N2, 
N3) of the tetradentate ligand. One water molecule 
(O7) and a chloride ion occupy the remaining cis-
positions. The trans-disposed Fe–O(phenolate) bonds 
are significantly different (Fe–O1, 1⋅890; Fe–O4, 
1⋅993 Å) but are similar to those in the previously 
reported17–19,22,24 six-coordinated iron(III) com-
plexes. This indicates the ability of the tripodal 
ligand to impose a difference in Fe–O bond lengths 
in spite of the similarity in the phenolate oxygen atoms. 
This is interesting because the difference in the two 
Fe-tyrosinate bonds in the 3,4-PCD enzyme is 
thought to influence the asymmetric binding of the 
chelated substrate moiety. The Fe–O–C bond angles 
(Fe–O1–C1, 135⋅3; Fe–O4–C14, 135⋅6°) are similar 
to those in 2 but greater than those in 1 and 5 and 
other octahedral iron(III) complexes of phenolate 
ligands (~ 128⋅5°) obviously due to the difference in 
phenolate substitution in the ligands; the dimethyl 
substituents on the phenolate moieties in 5 appear to 
provide no steric hindrance as revealed by space-
filling models, but electronic effects to stabilize the 
Fe–O (phenolate) coordination and hence the trigo-
nal bipyramidal coordination geometry. 
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 The Fe–Cl (2⋅271–2⋅339 Å) bond distances in 1, 2 
and 6 are in the same range as those for octahedral 
iron(III) complexes.17–19,22 The difference in bond 
lengths of cis chloride ions would encourage asym-
metric bidentate coordination of the catecholate sub-
strates, which is essential for substrate activation, 
subsequent reaction with molecular oxygen and re-
moval. This is relevant to the 4-HBA-PCD complex 
(4-HBA = 4-hydroxybenzoate) in which a doubly 
deprotonated form of 4-HBA is chelated.25 Interest-
ingly, there is only one Fe–Cl bond in 5. This is in-
teresting in view of the failure of this complex to 
catalyse the intradiol-cleavage (cf. below). 
4. Electronic absorption spectra 
The iron(III) monophenolate complexes 1–4 display 
the relatively intense band in the 535–550 nm re-
gion, which is assigned to phenolate (pi) → Fe(III) 
(dpi*) ligand to metal charge-transfer (LMCT) tran-
sition.26,27 On the other hand, the high energy band 
observed in the 425–435 nm range is assigned26 to 
phenolate (σ) → Fe(III) (dx2–y2/dz2) ligand to metal 
charge transfer transition. The band energy of the 
lowest energy LMCT band decreases in the order 
4 > 2 > 1 > 3, reflecting the increase in Lewis acid-
ity of the iron(III) centre in this order. On replacing 
the py moiety in 1 by the less strongly binding and 
sterically hindering –NMe2 group as in 2 the Lewis 
acidity increases. The negative charge built13 on 
iron(III) on replacing the py moiety in 2 by the more 
basic N-methylimidazole moiety to obtain 4 raises 
the iron d-orbital energy, leading to the higher 
LMCT band energy for 4. Similarly, the incorpora-
tion of the sterically demanding 6-Me group in 2 to 
obtain 3 would hinder the coordination of py nitro-
gen leading to a decrease in negative charge built on 
iron(III) and hence the lower LMCT band energy for 
3. Thus the Lewis acidity of the iron(III) centre is 
fine-tuned by modifying the ligand environment 
through the replacement of py moiety by imidazole 
moiety and suitable incorporation of methyl groups 
on the heterocyclic rings. 
 Two new visible bands (480–490, 635–800 nm, 
table 1), which appear on adding catecholate dian-
ions, are assignable to catecholate-to-Fe(III) LMCT 
transition28 involving two different catecholate orbi-
tals on the chelated catecholate. The position of the 
low rather than high energy LMCT band of the cate-
cholate adducts shows remarkable dependence on 
the nature of the primary ligand13–15,29,32 and, in fact, 
the magnitude of the energy of this band represents 
the Lewis acidity of the iron(III) centre as modified 
by the phenolate ligands. The low energy band of all 
the catecholates are shifted to lower energies on re-
placing the py moiety in [Fe(L1)(DBC)] by the less 
strongly binding and sterically hindering –NMe2 
group as in [Fe(L2)(DBC)] illustrating the impor-
tance of steric rather than electronic factors of the 
phenolate ligands. Similarly, on incorporating the 
sterically hindering 6-Me substituent as in [Fe(L3) 
(DBC)] the band is shifted to lower wavelength. Fur-
ther, on replacing the py moiety in [Fe(L2)(DBC)] by 
the strongly σ-bonding N-methyl-imidazole moiety to 
obtain [Fe(L4)(DBC)] the band is shifted17 to higher 
energy revealing that electronic effects are critical in 
catecholate adduct formation. 
 In the iron(III) bisphenolate complexes 5–8 the 
band in the range 335–430 nm is assigned to the 
charge transfer transition from the out-of-plane ppi 
orbital (HOMO) of the phenolate oxygen to the half-
filled dx2–y2/dz2 orbital of iron(III). The lowest energy 
band (475–550 nm) would arise from the charge 
transfer transition24,26,27 from the in-plane ppi orbital 
(POMO) of the phenolate ion to the half-filled dpi* 
orbital of iron(III). The shift of both these LMCT 
bands to lower energy is observed, on replacing the 
methyl groups in 5 by the electron-withdrawing p-
nitro group24 to obtain 6. This reflects the lower 
Lewis acidity of the iron centre in 5 compared to 6, 
which is supported by the shorter and hence stronger 
Fe–O bonds found in 5. The iron d-orbital energy in 
6 is raised by the negative charge built30 on Fe(III) 
by the stronger Fe–O (phenolate) bonds, as dis-
cussed above. Similar to 6, the introduction of p-
nitro group shifts the highest energy LMCT band in 
7 to lower energy in 8; however, the low energy 
LMCT band (550 nm) is shifted to higher energy 
(515 nm). Further, the tripodal ligand complexes 5 
and 6 exhibit the LMCT band at energies higher than 
their respective linear ligand complexes 7 and 8. 
 On adding catecholate anions to 6 and 8 two new 
catecholate → Fe(III) CT bands are observed.28 The 
blue shift of the high energy band indicates the con-
version of DBC2– ligand to a fairly basic ligand, 
which would be consistent with peroxide species in 
the proposed substrate activation mechanism for in-
tradiol–cleavage mechanism.31 In contrast to 6 and 
8, only one catecholate-to-Fe(III) LMCT band at a 
lower energy (475–540 nm) is obtained for 5 on the 
addition of catecholates. Also, the trend observed in 
the position of the band reflects the steric crowding 
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Table 1. Electronic spectral data, redox potential, kinetic data and percentage yield of cleavage pro-
ducts of iron(III) complexes18,19 
  E1/2 (V)  
 λmax, nm   
Complex  (ε, M–1 cm–1)  CVc DPV kO2 (M–1s–1)  (% yield) 
 
[Fe(L1)Cl2]  540 (3200) –0⋅294 –0⋅297 
 435 (2325) 
[Fe(L1)(DBC)] 780 (3570)  –  – – – 
 490 (3325) 
[Fe(L2)Cl2]  535 (3570) –0⋅262 –0⋅266 
 430 (3195) 
[Fe(L2)(DBC)] 790 (3260) – – 4⋅6 × 10–3 60⋅3 
 490 (3325) 
[Fe(L3)Cl2]  550 (3190) –0⋅176 –0⋅152 
 365 (13890) 
[Fe(L3)(DBC)] 800 (3465) – – – – 
 495 (3265) 
[Fe(L4)Cl2]  535 (3570)  –0⋅278 –0⋅280 
 425 (3645) 
[Fe(L4)(DBC)] 760 (2630)  – – 2⋅9 × 10–2  83⋅0 
 490 (3085) 
[Fe(L5)Cl] 475 (4530) –0⋅495 –0⋅483 
[Fe(L5)(DBC)] 540 (4530)  –0⋅320 –0⋅313 – – 
[Fe(L6)(H2O)Cl] 515 (3530)  –0⋅202 –0⋅205 
 430 (5510) 
[Fe(L6)(DBC)] 700 (15970)  –0⋅495 –0⋅525 3⋅8 × 10–3 100 
 410 (14780) –0⋅101 
[Fe(L7)Cl] 550 (2820)  –0⋅581 
 340 (4360) 
[Fe(L7)(DBC)] 545 (2670)  –0⋅883 – – 
 470 (2480)  –0⋅394 –0⋅395 
[Fe(L8)(H2O)Cl] 515 (4860)  –0⋅354 –0⋅345 
 425 (8250) 
[Fe(L8)(DBC)] 690 (2015)  –0⋅763 Very fast – 
 410 (25000) –0⋅191 –0⋅189 
 
 
and electronic effects provided by the catechols on 
binding to 5. Further, for 7 also only one but blue-
shifted (5–85 nm) LMCT band is observed. This is 
interesting in view of the failure of 5 and 7 to cata-
lyse the intradiol-cleavage (cf. below).  
5. Redox behaviour 
The electrochemical behaviour of the iron(III) mono- 
and bis-phenolato complexes were studied by em-
ploying cyclic (CV) and differential pulse voltam-
metry (DPV) using a stationary platinum sphere as 
working electrode and a non-aqueous Ag/Ag+ elec-
trode as reference. In methanol solution all the 
mono-phenolato complexes exhibit completely irre-
versible redox behaviour with a cathodic wave in the 
range 0⋅090–0⋅258 V (table 1), but with no anodic 
wave. All the bis-phenolato complexes show a ca-
thodic wave in the range –0⋅244 to –0⋅660 V (table 
1) and only the complexes 6 and 8 show the corre-
sponding anodic wave (2, – 0⋅160; 8, – 0⋅308 V). For 
all the complexes, the plots of ipc vs ν1/2 (ν < 0⋅5 Vs–1) 
are linear, revealing a diffusion controlled redox 
process. The values of diffusion coefficients (D, 1⋅5 
–
 6⋅8 × 10–6 cm2/s) calculated by assuming reversi-
bility fall in the range observed for other iron(III) 
complexes.17 The FeIII/FeII redox potentials of the 
mono-phenolato complexes 1–4 are more negative 
than that for [Fe(TPA)Cl2]Cl complex17 and those of 
bis-phenolato complexes 5–8 are more negative than 
the former illustrating that incorporation of iron(III)-
phenolate bond stabilizes the iron(III) oxidation 
state. 
 The E1/2 values of FeIII/FeII redox potentials of the 
monophenolato complexes follow the trend 3 > 2 > 
4 > 1, which represents the decrease in Lewis acidity 
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Scheme 3. Cleavage products of H2DBC mediated by iron(III) complexes: 3,5-di-tert-butyl-1-oxacyclohepta-
3,5-diene-2,7-dione (9), 3,5-di-tert-butyl-5-(N,N-dimethylamidomethyl)-2-furanone (10), 3,5-di-tert-butyl-5-(2-
oxo-2-piperidinylethyl)-5H-furanone (11), 3,5-di-tert-butyl-5-formyl-2-furanone (12), 3,5-di-tert-butyl-2-pyrone 
(13), 4,6-di-tert-butyl-2-pyrone (14), 3,5-di-tert-butyl-2-hydroxy-1,4-benzoquinone (15), 2,5-di-tert-butyl-2H-
pyran-3,6-dione (16), 3-tert-butylfuran-2,5-dione (17). 
 
 
of the iron(III) centre, consistent with the above 
spectral results. On replacing the pyridyl arm in 1 by 
–NMe2 group to obtain 2 the iron(III) centre is de-
stabilised due to weak σ-bonding interaction by the 
sterically demanding –NMe2 group (cf. above). 
Similarly, on introducing the sterically hindering 6-
methyl group on the pyridyl ring in 2 to give 3, the 
iron(III) oxidation state is destabilised (cf. above). 
The Lewis basicity of N-methylimidazole moiety in 
L4, which is higher than that of pyridine moiety in 
L2, leads to enhanced stabilization of iron(III) oxi-
dation state in 4, rendering its FeIII/FeII redox poten-
tial more negative. The E1/2 values for FeIII/FeII 
couple of 5–8 exhibit the following trends: 5 < 6, 
7 < 8; this reflects the increase in Lewis acidity of 
the iron(III) centre as the electron-releasing methyl 
groups on the phenolate donors are replaced by the 
p-NO2 group. The trend in Lewis acidity of 5 and 6 
is consistent with that derived from PhO– → Fe(III) 
LMCT band energies. Interestingly, the redox poten-
tials of linear ligand complexes 6 and 8 are more 
negative than the respective tripodal ligand com-
plexes 5 and 7. This is consistent with the trend ob-
served in the energies of LMCT bands and suggests 
that linear ligands are more suitable than tripodal 
ligands to strongly bind to and hence confer de-
creased Lewis acidity on iron(III) centre. The ap-
pearance of the DBC2– → Fe(III) LMCT band and 
DBSQ/DBC2– redox wave and the lowering of the 
Fe(III)/Fe(II) redox potential on adding H2DBC 
even in the absence of added base illustrate the 
spontaneous deprotonation of the latter on binding 
to iron(III). 
6. Catechol 1,2-dioxygenase activity 
The 3,5-di-tert-butylcatecholate (DBC2–) adducts of 
the present complexes were generated in situ in 
DMF solution and their reactivity towards O2 was 
investigated by monitoring the decay of DBC2–. Inter-
estingly, only 2⋅DBC2–, 4⋅DBC2–, 6⋅DBC2– and 8. 
DBC2– were found to react. While 8 reacted very 
fast, the other complexes exhibit a pseudo-first-order 
kinetics due to excess of dioxygen used, as judged 
from the linearity of the plot of [1 + log(Abs)] vs 
time. The rates of the reactions (table 1) were calcu-
lated30,32 by using the equation, 
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Both GC and GC–MS techniques were used to iden-
tify and quantify the oxidative intradiol (9, 10, 11, ta-
ble 1, scheme 3) and very small amounts of extradiol 
(12–14) and side (15–17) products of H2DBC. The 
products 10 and 11 are derived15 from the nucleo-
philic attack respectively of Me2NH as impurity in 
DMF and piperidine on cis,cis-muconic anhydride 
(9), which is the immediate product of oxidative 
cleavage. From the reaction mixture two intradiol 
(9, 61, 10, 25%) and one extradiol (13, 14%) cleav-
age products were identified for 6. In contrast, inter-
estingly, only one intradiol cleavage product 9 was 
identified for 8. 
 Very low amounts of the extradiol products are 
expected because the six-coordinate catecholate ad-
ducts of 2, 4, 6 and 8 have no vacant coordination 
site for O2 to attack.25 Since mainly intradiol cleav-
age products were obtained, the oxidative reactions 
catalysed by the complexes correspond exclusively 
to intradiol-cleavage pathway; hence the trend in re-
activity of these adducts may be illustrated by in-
voking the novel substrate-activation mechanism 
proposed31,33,34 for the intradiol-cleaving dioxy-
genase enzymes. The incorporation of a coordinated 
phenolic hydroxyl group into [Fe(TPA)(DBC)]+ 
(kO2, 1.5 × 103 M–1 s–1)33 as in [Fe(HDP)(DBC)] 
[H(HDP) = 2-[(bis(2-pyridylmethyl)-aminomethyl]-
4,6-dimethylphenol]14 decreases the Lewis acidity of 
the iron(III) centre and hence lowers the rate of di-
oxygenation enormously (kO2, 3.3 × 10–3 M–1 s–1). On 
the other hand, the incorporation of p-nitrophenolate 
moiety as in 1 leads to lack of reactivity towards di-
oxygen and H2O2 as well.16 The p-nitrophenolate 
donor, as it is weakly σ-bonding, does not appear to 
facilitate the decomposition of the reaction interme-
diate into products (cf. above). Also, on replacing 
one of the pyridyl moieties in 1 by the –NMe2 pen-
dant to obtain 2 the dioxygenase activity is restored; 
obviously, the weak coordination of the sterically 
hindering –NMe2 group (cf. above) enhances the 
Lewis acidity of the iron(III) centre sufficiently 
thereby increasing the reaction rate. Further, as pre-
viously demonstrated by Que13,14,33 and Palanianda-
var,17–19 the higher Lewis acidity of the iron(III) 
centre in 2 (cf. above) would be expected to confer a 
higher rate of oxygenation on 2⋅DBC2–. But, inter-
estingly, the latter reacts (kO2, 2⋅9 × 10–2 M–1 s–1) ap-
proximately six times slower than 4⋅DBC2– does 
(kO2, 4⋅6 × 10–3 M–1s–1), which is consistent with the 
former displaying a more efficient conversion of the 
substrate to intradiol products than the latter (4, 10, 
1⋅0; 11, 52⋅6%; 2: 10, 1⋅5; 11, 75⋅6%). The dissocia-
tion of the reaction intermediate into products, 
which is possibly the rate-determining phase of oxy-
genation reaction as for the enzymes,31 appears to be 
facilitated by the more basic N-methylimidazole 
moiety in 4, leading to the observed higher rate of 
catechol cleavage. Similar enhancement in rates 
have been observed by us19 and Krebs et al24 previ-
ously. 
 Further, on replacing the pendant py moiety in 2 
by one more pendant p-nitrophenolate moiety to ob-
tain 6 only a slight decrease in reaction rate is ob-
served (kO2, 3⋅8 × 10–3 M–1 s–1).19 This is consistent 
with the presence of trans-disposed and significantly 
different (1⋅890, 1⋅993 Å)19 Fe–O (p-nitrophenolate) 
bonds, which facilitate the unsymmetrical chela-
tion26 of catecholate and hence the release of prod-
ucts from reaction intermediates.13 A similar higher 
rate of cleavage and higher cleavage yield have been 
noted respectively by Krebs et al24 and Palanianda-
var et al17 for certain bis(phenolate)iron(III) com-
plexes. Furthermore, the inactivity of 3 towards 
catechol cleavage, in spite of enhanced Lewis acid-
ity of its iron(III) centre, is intriguing. The sterically 
high demanding 6-methyl group in this adduct ap-
pears to hinder the approach of dioxygen. A similar 
dioxygenation activity of [Fe(MeTPA)Cl2]35 
[MeTPA = (6-methylpyrid-2-ylmethyl)bis(pyrid-2-
ylmethyl)amine] extremely lower than [Fe(TPA)Cl2]Cl 
has been noticed previously.  
 The rate of the reaction calculated for 6 is 
3⋅76 × 10–3 M–1 s–1 and 8 reacts very fast. The latter 
with a Lewis acidity lesser than the former (cf. 
above) would be expected to exhibit a lower rate of 
dioxygenase reaction. However, interestingly, 8 re-
acts much faster13 than 2. Unlike the tripodal ligand 
complex 6, the linear tetradentate ligand in 8 should 
rearrange itself to provide cis-coordination positions 
for bidentate coordination of the catechol substrate. 
The increased steric congestion and the enhanced 
negative charge built on iron(III) in 8.DBC2– com-
pared to 6⋅DBC2– adduct would facilitate the rate-
determining product-releasing phase in the reaction 
mechanism proposed by Que et al for intradiol-
cleaving dioxygenases. Also it is relevant to note 
that the reactivities of iron(III) complexes of tetra-
dentate tripodal ligands differ from those of tetra-
dentate macrocyclic ligands. 
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7. Conclusions and relevance to iron oxygenases 
To conclude, the mononuclear iron(III) complexes of 
sterically hindered tripodal mono- and bis-phenolate 
ligands offering N3O and N2O2 donor sets have been 
studied as structural, spectral and functional models 
for the intradiol-cleaving catechol 1,2-dioxygenase 
enzymes. It is remarkable that suitably tailored – 
sterically hindered and strongly Lewis basic – bis 
(phenolate) ligands can stabilize five-coordinate 
iron(III) geometries, which closely mimic the active 
site geometry of the intradiol-cleaving enzymes and 
confer interesting spectral and chemical properties. 
In the X-ray crystal structure of two of these com-
plexes the tripodal ligands are coordinated to the 
iron(III) centre with a distorted octahedral coordina-
tion geometry. Interestingly, the Fe–O–C bond angle 
of 136⋅1° observed for the complexes is higher than 
the average Fe–O–C bond angle of ~ 128⋅5° reported 
for other octahedral iron(III)-phenolate complexes. 
This structural feature, which originates from the 
other donors of the phenolate ligand, namely, the 
sterically demanding –NMe2 group, leads to an en-
hanced rate of catechol cleavage. This is relevant to 
the stereochemical constraints in the 3,4-PCD en-
zymes, the function of which is traced to the quite 
different equatorial and axial Fe–O (tyrosinate) bond 
distances (1⋅81, 1⋅91 Å), as determined by the Fe–O–
C bond angles (133, 148°) and Fe–O–C–C dihedral 
angles (68, 24°). 
 A noteworthy observation is that the substituents 
on the phenolate ligands tend to tune the Lewis acid-
ity of the iron(III) centre and hence determine the 
course and products of dioxygenase activity of the 
complexes. Thus the ligand donor functionalities  
–NMe2, (6-methyl)pyridine and N-methylimidazole 
exhibit different stereoelectronic effects in clearly 
influencing the shielding of the iron(III) centre and 
hence its Lewis acidity, as demonstrated by the spectral 
and electrochemical properties. It is remarkable that 
the imidazole-based complex confers enhanced reac-
tion rate with efficient conversion of substrate to in-
tradiol cleavage products. The rates of dioxygenase 
reaction of the complexes could be illustrated not on 
the basis of the Lewis acidity of the iron(III) centre 
alone but by assuming that product release is the 
rate-determining phase of the catalytic reaction, 
lending support to the electron-transfer mediated 
substrate activation mechanism proposed by Que 
and coworkers.  
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